Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
*Correspondence: Rong Lin, [email protected] This article was submitted to Gut Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
GLP-1 Monotherapy Exenatide Exenatide (Byetta, Bydureon) was the first approved GLP-1 analogue in 2005, a synthetic form of the naturally occurring peptide exendin-4 first isolated from Heloderma suspectum (Gila Monster) lizard venom in 1992 [25]
Lean proteins, fruits, vegetables, and whole grains move through your digestive system more efficiently
Sandoz and Samsung Bioepis partner to develop and commercialise up to five next-generation biosimilars, starting with an Entyvio-referencing asset
